相关实验视频
Updated: Jun 21, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
在患有慢性病的患者中预防心力衰竭
Amr Raghban1, Jennifer Kirsop2, W H Wilson Tang1,2
1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH 44195, USA.
Current cardiovascular risk reports
|July 12, 2024
概括
患有慢性病 (CKD) 的患者面临心力衰竭 (HF) 的高风险. 使用生物标志物,生活方式变化和特定药物的早期干预可以帮助预防HF在这个人群中的发展和进展.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 临床药理学 临床药理学
背景情况:
- 患有慢性病 (CKD) 的患者患心力衰竭 (HF) 的风险较高.
- 有限的研究集中在特定的病理生理机制和预防性治疗的HF在CKD患者.
- 识别高风险个体对于及时干预至关重要.
研究的目的:
- 审查CKD和HF之间的病理生理学联系.
- 探索用于风险分层的诊断生物标志物.
- 评估目前和潜在的治疗策略,以预防HF在CKD.
主要方法:
- 临床研究和指导方针的文献综述.
- 对心脏和脏生物标志物的数据分析.
- 对药理干预措施的证据评估.
主要成果:
- 临床上可用的生物标志物可以识别患有HF风险的CKD患者.
- 建议改变饮食和生活方式 (运动,戒烟).
- 控制风险因素 (血压,葡萄糖,脂质) 是非常重要的.
- ангиотензин转化酶抑制剂和 ангиотензин受体抑制剂显示出一致的风险降低.
- 贝塔抑制剂和矿物质皮质类受体对抗剂显示出有希望的结果,但缺乏大规模试验证据来预防CKD中的HF.
结论:
- 慢性瘤对HF发育构成重大风险.
- 包括生物标志物,生活方式变化和向药物治疗在内的多方面的方法是预防CKD中HF所必需的.
- 需要进行进一步的临床试验,以确定某些HF药物在这个人群中的作用.
相关概念视频
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:11Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
01:27Dialysis
288
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288